Cargando…
Endothelin-1: Is it Time to “Biomark” the Cardiac-Tumor-Treatment Nexus in Breast Cancer?
[Figure: see text]
Autores principales: | Valero-Muñoz, María, Sam, Flora |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10635882/ https://www.ncbi.nlm.nih.gov/pubmed/37969651 http://dx.doi.org/10.1016/j.jaccao.2023.05.007 |
Ejemplares similares
-
Endothelin-1 Enriched Tumor Phenotype Predicts Breast Cancer Recurrence
por: Tamkus, Deimante, et al.
Publicado: (2013) -
Endothelin Receptor Blocker Reverses Breast Cancer–Induced Cardiac Remodeling
por: Maayah, Zaid H., et al.
Publicado: (2023) -
YAP: The nexus between metabolism and cardiac remodeling
por: Gao, Chen, et al.
Publicado: (2022) -
The Tumor Suppressor Kinase LKB1: Metabolic Nexus
por: Bourouh, Mohammed, et al.
Publicado: (2022) -
Role of Endothelin in the Induction of Cardiac Hypertrophy In Vitro
por: Bupha-Intr, Tepmanas, et al.
Publicado: (2012)